Related Experiment Video
Updated: May 21, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
IDO Believe in Immunotherapy
1City of Hope Comprehensive Cancer Center, Duarte, United States.
Indoleamine 2,3-dioxygenase 1 is central to immune downregulation. A recent phase I/II study tested the indoleamine 2,3-dioxygenase 1 inhibitor linrodostat with nivolumab ± ipilimumab in patients with advanced solid tumors. Although efficacy was not augmented, correlative analyses identified tryptophan 2,3 dioxygenase as a resistance mechanism; dual targeting may be necessary to realize improved response to PD-1 inhibition. See related article by Luke et al., p. 2134.
Indoleamine 2,3-dioxygenase 1 is central to immune downregulation. A recent phase I/II study tested the indoleamine 2,3-dioxygenase 1 inhibitor linrodostat with nivolumab ± ipilimumab in patients with advanced solid tumors. Although efficacy was not augmented, correlative analyses identified tryptophan 2,3 dioxygenase as a resistance mechanism; dual targeting may be necessary to realize improved response to PD-1 inhibition. See related article by Luke et al., p. 2134.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

